🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of avelumab ...
Status
Active Not Recruiting
Location
Beacon Cancer Care
Start Date
2022-08-17
Trial ID
NCT05327530
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of avelumab wi...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-03-17
Trial ID
NCT04266912
Treatments Being Tested
The purpose of this study was to evaluate the maximum tolerated dose (MTD) ...
Status
Completed
Location
Research site
Start Date
2018-04-24
Trial ID
NCT03523390
Treatments Being Tested
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
Phase 1 open-label, dose-escalation and dose-expansion study of INI-4001 as...
Status
Recruiting
Location
The Border Cancer Hospital
Start Date
2024-07-01
Trial ID
NCT06302426
Treatments Being Tested
The purpose of the study is to find out if the study drugs Avelumab, Cetuxi...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2018-06-06
Trial ID
NCT03498378
Treatments Being Tested
Background: Pancreas cancer ranks 4th in all cancer-related deaths in the ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2018-05-17
Trial ID
NCT03451773
Treatments Being Tested
This is a non-profit phase II, open-label, single-arm study of cetuximab pl...
Status
Completed
Location
Università della Campania Luigi Vanvitelli
Start Date
2018-08-10
Trial ID
NCT04561336
The purpose of the study is to evaluate the safety and preliminary efficacy...
Status
Completed
Location
Sarcoma Oncology Research Center
Start Date
2019-07-15
Trial ID
NCT03941262
Treatments Being Tested
The main purpose of the study was to evaluate a safe, tolerable recommended...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute, Inc
Start Date
2018-11-27
Trial ID
NCT03724890
Treatments Being Tested